Adbry Injection, Solution
Product Images NDC 50222-346

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Adbry (NDC 50222-346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leo Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Tralokinumab 01)

This text provides instructions for the use of a medical syringe. It mentions the use of a needle guard and the importance of checking the expiration date on the label. It also instructs the user to administer two separate injections using pre-filled syringes to receive a full dose. There is no mention of the specific medication or condition being treated.*

FDA Label Image

Figure B (Tralokinumab 02)

ADBRY prefilled syringes are medical devices designed for the administration of medication through injection. The text only provides the name of the product and does not provide any further useful description.*

FDA Label Image

Figure C (Tralokinumab 03)

FDA Label Image

Figure D (Tralokinumab 04)

FDA Label Image

Figure E (Tralokinumab 05)

FDA Label Image

Figure F (Tralokinumab 06)

FDA Label Image

Figure G (Tralokinumab 07)

This text suggests that a certain injection can only be administered by a caregiver and not by the individual receiving the injection. The letter "B" preceding "Selfinjection or by caregiver" may indicate that there is an option for self-injection, but further information is needed to confirm this.*

FDA Label Image

Figure H (Tralokinumab 08)

FDA Label Image

Figure I (Tralokinumab 09)

FDA Label Image

Figure J (Tralokinumab 10)

FDA Label Image

Figure K (Tralokinumab 11)

FDA Label Image

Figure L (Tralokinumab 12)

FDA Label Image

Figure M (Tralokinumab 13)

FDA Label Image

Figure N (Tralokinumab 14)

FDA Label Image

Principal Display Panel (150 mg/mL Syringe Carton)

This is a description of a medication called "T". It is in the form of an injection and comes in two syringes. Each syringe contains 150 mg/mL of the medication. The medication is intended for subcutaneous use only. The carton contains two single-dose prefilled syringes with needle guard. The medication must be stored refrigerated between 2°C to 8°C and protected from light. Additional instructions for use and patient information are available in the package.*

FDA Label Image

Principal Display Panel (150 mg/mL Syringe Carton)

Description: Adbry is a drug that comes in the form of an injection with a concentration of 150mg/mL per syringe. It is only for subcutaneous use and is packaged in a multi-pack of four 2mL single-dose prefilled syringes, which provide a total of 800mg. The drug should be stored between 2°C to 8°C, and the original carton should be used to protect it from light.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.